Tumour CD274 (PD-L1) expression and T cells in colorectal cancer
Yohei Masugi(Tokai University), Shuji Ogino(Broad Institute), Mingyang Song(Guangzhou University), Yin Cao(Anhui University of Traditional Chinese Medicine), Kosuke Mima(Dana-Farber Cancer Institute), Annacarolina da Silva(Cornell University), Juhong Yang(Harvard University), Marios Giannakis(Broad Institute), Charles S. Fuchs(University of Southern California), Katsuhiko Nosho(Harvard University), Jonathan A. Nowak(Brigham and Women's Hospital), Scott J. Rodig(Brigham and Women's Hospital), Andrew T. Chan(Harvard University), Gordon J. Freeman(Dana-Farber Cancer Institute), Xiaoyun Liao(Bristol-Myers Squibb (Germany)), Adam J. Bass(Dana-Farber Cancer Institute), F. Stephen Hodi(Harvard University), Reiko Nishihara(Harvard University), Kentaro Inamura(Jichi Medical University), Zhi Rong Qian(Dana-Farber Cancer Institute), Yan Shi(Hebei Provincial Center for Disease Control and Prevention)
Cited by 240
Related Papers
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
|New England Journal of Medicine|2012|12.6k
Comprehensive molecular characterization of gastric adenocarcinoma
|Nature|2014|6.6k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k
Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma
|New England Journal of Medicine|2013|3.4k